Reply Full Year 2023 Earnings: EPS: €5.01 (vs €5.13 in FY 2022)

Reply (BIT:REY) Full Year 2023 Results

Key Financial Results

• Revenue: €2.14b (up 12% from FY 2022).
• Net income: €186.7m (down 2.3% from FY 2022).
• Profit margin: 8.7% (down from 10.0% in FY 2022). The decrease in margin was driven by higher expenses.
• EPS: €5.01 (down from €5.13 in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Reply Earnings Insights

The primary driver behind last 12 months revenue was the Region 1 segment contributing a total revenue of €1.34b (63% of total revenue). Notably, cost of sales worth €1.78b amounted to 83% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling €90.2m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how REY's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 10% growth forecast for the IT industry in Italy.

Performance of the Italian IT industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Reply's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.